Free Trial

Bright Minds Biosciences (DRUG) Short Interest Ratio & Short Volume

Bright Minds Biosciences logo
$39.75 +0.93 (+2.40%)
(As of 12/17/2024 ET)

Bright Minds Biosciences Short Interest Data

Bright Minds Biosciences (DRUG) has a short interest of 221,400 shares, representing 4.38% of the float (the number of shares available for trading by the public). This marks a -16.39% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 835,874 shares to cover all short positions.

Current Short Interest
221,400 shares
Previous Short Interest
264,800 shares
Change Vs. Previous Month
-16.39%
Dollar Volume Sold Short
$9.74 million
Short Interest Ratio
0.1 Days to Cover
Last Record Date
November 30, 2024
Outstanding Shares
4,434,000 shares
Float Size
5,060,000 shares
Short Percent of Float
4.38%
Today's Trading Volume
70,106 shares
Average Trading Volume
835,874 shares
Today's Volume Vs. Average
8%
Short Selling Bright Minds Biosciences?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Bright Minds Biosciences and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

DRUG Short Interest Over Time

DRUG Days to Cover Over Time

DRUG Percentage of Float Shorted Over Time

Bright Minds Biosciences Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
11/30/2024221,400 shares $9.74 million -16.4%4.4%0.1 $44.00
11/15/2024264,800 shares $10.49 million -17.9%5.2%0.1 $39.61
10/31/2024322,600 shares $15.10 million -72.4%11.7%0.1 $46.80
10/15/20241,170,000 shares $45.03 million +1,274.9%38.2%0.4 $38.49
9/30/202485,100 shares $99,567.00 -19.6%3.0%0.8 $1.17
9/15/2024105,900 shares $135,022.50 -41.7%3.7%1 $1.28
8/31/2024181,500 shares $192,390.00 +149.7%6.3%1.8 $1.06
8/15/202472,700 shares $74,881.00 +0.6%2.5%0.8 $1.03
7/31/202472,300 shares $83,868.00 +3.6%2.5%3.4 $1.16
7/15/202469,800 shares $71,196.00 -2.0%2.4%3 $1.02
6/30/202471,200 shares $77,223.52 -0.4%2.5%6 $1.08
6/15/202471,500 shares $75,075.00 -13.5%2.5%4.5 $1.05
5/31/202482,700 shares $100,067.00 +17.5%2.9%4.4 $1.21
5/15/202470,400 shares $76,384.00 No Change2.5%3.6 $1.09
4/30/202470,400 shares $70,400.00 -7.0%2.6%3.3 $1.00
4/15/202475,700 shares $93,111.00 +7.2%2.8%3.1 $1.23
3/31/202470,600 shares $84,712.94 -3.6%2.6%2.5 $1.20
3/15/202473,200 shares $95,160.00 +3.1%2.7%2.2 $1.30
2/29/202471,000 shares $127,800.00 +0.3%2.6%2 $1.80
2/15/202470,800 shares $138,760.92 -0.4%2.5%1.9 $1.96
1/31/202471,100 shares $151,443.00 -9.1%2.9%2 $2.13
1/15/202478,200 shares $151,012.02 +7.6%3.2%2.6 $1.93
12/31/202372,700 shares $103,961.00 -5.6%3.0%2.4 $1.43
12/15/202377,000 shares $115,500.00 -9.4%3.0%3.3 $1.50
11/30/202385,000 shares $113,900.00 +21.6%3.3%3.6 $1.34
11/15/202369,900 shares $88,773.00 -1.4%2.7%2.3 $1.27
10/31/202370,900 shares $95,715.00 -1.3%2.7%1.1 $1.35
10/15/202371,800 shares $112,008.00 -1.0%2.8%0.1 $1.56
9/30/202372,500 shares $116,000.00 -1.0%2.8%0.1 $1.60
9/15/202373,200 shares $114,924.00 -12.8%2.8%0.1 $1.57
8/31/202383,900 shares $180,385.00 -50.7%3.2%0.1 $2.15
8/15/2023170,200 shares $451,030.00 +49.3%6.6%0.3 $2.65
7/31/2023114,000 shares $474,240.00 +16.9%4.4%0.2 $4.16
7/15/202397,500 shares $358,800.00 -80.7%3.8%0.9 $3.68
6/30/2023505,400 shares $1.44 million -7.5%3.8%0.7 $2.85
6/15/2023546,300 shares $319,694.76 -19.8%4.1%0.8 $0.59
5/31/2023680,900 shares $427,060.48 +15.9%4.8%1 $0.63
5/15/2023587,600 shares $317,304.00 -13.0%4.1%0.9 $0.54
4/30/2023675,000 shares $424,372.50 +38.2%4.7%1 $0.63
4/15/2023488,600 shares $200,277.14 +2.2%3.4%0.7 $0.41
URGENT: This Altcoin Opportunity Won’t Wait – Act Now (Ad)

Crypto has officially entered the "banana zone" – that wild phase where prices can 1000x in days. It happens like clockwork every 4 years, during the December to February window of a Bitcoin halving year. This is where fortunes are made – often LITERALLY overnight.

3/31/2023478,100 shares $210,411.81 -0.1%3.4%3.7 $0.44
3/15/2023478,500 shares $229,680.00 +0.8%3.4%2.8 $0.48
2/28/2023474,800 shares $273,603.50 -22.4%3.3%2.5 $0.58
2/15/2023612,100 shares $448,669.30 +4.3%4.4%2.8 $0.73
1/31/2023586,900 shares $422,157.17 +11.6%4.2%2.2 $0.72
1/15/2023525,700 shares $415,303.00 -21.8%3.8%1.9 $0.79
12/30/2022672,200 shares $497,428.00 -17.9%4.9%1.1 $0.74
12/15/2022818,500 shares $746,881.25 -0.8%8.3%1.2 $0.91
11/30/2022824,900 shares $899,141.00 -11.6%11.0%0.6 $1.09
11/15/2022932,900 shares $918,906.50 +23.0%12.5%0.1 $0.99
10/31/2022758,600 shares $751,014.00 +58.5%10.1%0.1 $0.99
10/15/2022478,500 shares $435,482.85 +34.6%6.4%0 $0.91
9/30/2022355,600 shares $437,388.00 -24.6%4.9%0 $1.23
9/15/2022471,600 shares $603,648.00 -58.6%6.5%0 $1.28
8/31/20221,140,000 shares $2.19 million +1,809.6%16.3%0.1 $1.92
8/15/202259,700 shares $59,538.81 +64.9%0.9%0 $1.00
7/31/202236,200 shares $36,022.62 +10.0%0.5%0.6 $1.00
7/15/202232,900 shares $28,043.93 +56.7%0.5%0.6 $0.85
6/30/202221,000 shares $16,793.70 -56.3%0.3%0.4 $0.80
6/15/202248,100 shares $44,405.92 +2.3%0.7%0.6 $0.92
5/31/202247,000 shares $51,700.00 +144.8%0.7%0.5 $1.10
5/15/202219,200 shares $18,721.92 -28.9%0.3%0.2 $0.98
4/30/202227,000 shares $25,245.00 -26.0%0.4%0.3 $0.94
4/15/202236,500 shares $46,997.40 -21.3%0.6%0.5 $1.29
3/31/202246,400 shares $70,393.44 +29.3%0.7%0.8 $1.52
3/15/202235,900 shares $55,645.00 -29.1%0.6%0.9 $1.55
2/28/202250,600 shares $105,754.00 +13.7%0.8%3.6 $2.09
2/15/202244,500 shares $107,690.00 -11.9%0.7%2.2 $2.42
1/31/202250,500 shares $122,715.00 +6.3%0.7%0.3 $2.43
1/15/202247,500 shares $135,850.00 +43.5%0.7%0.3 $2.86
12/31/202133,100 shares $104,927.00 No Change0.5%0.2 $3.17

DRUG Short Interest - Frequently Asked Questions

What is Bright Minds Biosciences' current short interest?

Short interest is the volume of Bright Minds Biosciences shares that have been sold short but have not yet been covered or closed out. As of November 30th, investors have sold 221,400 shares of DRUG short. 4.38% of Bright Minds Biosciences' shares are currently sold short. Learn More on Bright Minds Biosciences' current short interest.

What is a good short interest percentage for Bright Minds Biosciences?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.38% of Bright Minds Biosciences' floating shares are currently sold short.

Is Bright Minds Biosciences' short interest increasing or decreasing?

Bright Minds Biosciences saw a drop in short interest in the month of November. As of November 30th, there was short interest totaling 221,400 shares, a drop of 16.4% from the previous total of 264,800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Bright Minds Biosciences' float size?

Bright Minds Biosciences currently has issued a total of 4,434,000 shares. Some of Bright Minds Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Bright Minds Biosciences currently has a public float of 5,060,000 shares.

How does Bright Minds Biosciences' short interest compare to its competitors?

4.38% of Bright Minds Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Bright Minds Biosciences: Dianthus Therapeutics, Inc. (29.30%), Rapport Therapeutics (10.25%), Autolus Therapeutics plc (2.36%), Oculis Holding AG (0.10%), Cullinan Therapeutics, Inc. (24.72%), Prothena Co. plc (14.98%), Entrada Therapeutics, Inc. (7.02%), Arbutus Biopharma Co. (3.07%), Tectonic Therapeutic (6.13%), Stoke Therapeutics, Inc. (12.71%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: AppLovin Co. ($5.70 billion), Charter Communications, Inc. ($4.55 billion), Spotify Technology S.A. ($3.84 billion), Royal Caribbean Cruises Ltd. ($3.07 billion), International Paper ($3.00 billion), Coinbase Global, Inc. ($2.93 billion), Cencora, Inc. ($2.54 billion), Paychex, Inc. ($2.53 billion), SoFi Technologies, Inc. ($2.24 billion), and Reddit, Inc. ($2.00 billion). View all of the most shorted stocks.

What does it mean to sell short Bright Minds Biosciences stock?

Short selling DRUG is an investing strategy that aims to generate trading profit from Bright Minds Biosciences as its price is falling. DRUG shares are trading up $0.93 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Bright Minds Biosciences?

A short squeeze for Bright Minds Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of DRUG, which in turn drives the price of the stock up even further.

How often is Bright Minds Biosciences' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including DRUG, twice per month. The most recent reporting period available is November, 30 2024.




This page (NASDAQ:DRUG) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners